Mueller Brian Insider Trades

Insider Trading History

Track insider trading activity for Mueller Brian. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Financial Officer
Holding Value $6.97M 123,314 shares
Last Trade
Mar 17, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$119k 2,117 shares
$56.05
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Financial Officer
Holding Value $7.09M 125,431 shares
Last Trade
Mar 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.64M 63,340 shares
$57.43
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Financial Officer
Holding Value $6.03M 106,691 shares
Last Trade
Mar 13, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$582k 9,945 shares
$58.51
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Financial Officer
Holding Value $6.59M 116,638 shares
Last Trade
Feb 25, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.01M 16,482 shares
$61.44
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Financial Officer
Holding Value $5.64M 99,781 shares
Last Trade
Mar 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.76M 38,590 shares
$71.55
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Financial Officer
Holding Value $4.7M 83,141 shares
Last Trade
Mar 14, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.28M 18,497 shares
$69.44
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Financial Officer
Holding Value $4.04M 71,571 shares
Last Trade
Jun 28, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$48.4k 588 shares
$82.33
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Financial Officer
Holding Value $4.08M 72,159 shares
Last Trade
May 30, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$376k 5,000 shares
$75.19
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
May 30, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$372k 5,000 shares
$74.48
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Financial Officer
Holding Value $4.36M 77,159 shares
Last Trade
May 30, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$372k 5,000 shares
$74.48
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Financial Officer
Holding Value $4.08M 72,159 shares
Last Trade
Apr 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.2k 300 shares
$80.76
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Financial Officer
Holding Value $4.06M 71,859 shares
Last Trade
Mar 15, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.74M 20,789 shares
$83.87
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Financial Officer
Holding Value $5.23M 92,648 shares
Last Trade
Mar 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.14M 25,540 shares
$83.87
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Financial Officer
Holding Value $2.88M 50,983 shares
Last Trade
Jun 29, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$409k 4,602 shares
$88.93
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Financial Officer
Holding Value $3.14M 55,585 shares
Last Trade
Mar 16, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$371k 3,973 shares
$93.41
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Financial Officer
Holding Value $3.52M 62,266 shares
Last Trade
Mar 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.77M 31,600 shares
$87.74
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Financial Officer
Holding Value $3.37M 59,558 shares
Last Trade
Mar 15, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$238k 2,708 shares
$87.74
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Financial Officer
Holding Value $2.97M 52,636 shares
Last Trade
Feb 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.48M 24,890 shares
$99.59
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Financial Officer
Holding Value $1.71M 30,246 shares
Last Trade
Jan 13, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$282k 2,500 shares
$112.72
$56.50
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Evp, Chief Financial Officer
Holding Value $1.57M 27,746 shares
Last Trade
Jan 13, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$286k 2,500 shares
$114.50
$56.50

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up